Product image of Hemovás (Pentoxifylline) supplied by GNH India

Hemovás

Active Ingredient:
Pentoxifylline
Origin:
EU

Hemovás (Pentoxifylline)

Hemovás is a prescription oral medication whose active ingredient is pentoxifylline; the exact strength and dosage form are not specified in the product listing. Pentoxifylline is a phosphodiesterase inhibitor used as a vasodilator to enhance peripheral blood flow. The product is marketed in the European Union and is available only with a prescription, primarily for patients with chronic circulation disorders of the legs and veins.

Manufacturer / TM Owner

Ferrer Internacional, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hemovás (pentoxifylline) is indicated for several vascular conditions where improved microcirculatory flow is desired.

  • Intermittent claudication due to peripheral arterial disease
  • Chronic venous insufficiency with edema or ulceration
  • Peripheral vascular disease affecting lower extremities
  • Adjunctive therapy to reduce blood viscosity in patients with microvascular disorders

Side Effects

Side‑effect profiles for pentoxifylline are generally mild, but some reactions may require medical attention.

Common

  • Nausea or upset stomach
  • Headache
  • Dizziness or light‑headedness
  • Flushing or warmth sensation
  • Diarrhea

Serious

  • Severe allergic reaction (rash, itching, swelling, difficulty breathing)
  • Chest pain or palpitations
  • Unexplained bleeding or bruising
  • Low blood pressure causing faintness

Precautions & Warnings

Before prescribing Hemovás, clinicians should evaluate several safety considerations.

  • Use with caution in patients with recent myocardial infarction or unstable angina
  • Assess renal or hepatic impairment, as dose adjustment may be needed
  • Avoid in patients with known hypersensitivity to pentoxifylline or related compounds
  • Monitor blood pressure in individuals prone to hypotension
  • Consider potential effects on bleeding risk, especially in those on anticoagulants
  • Use during pregnancy only if potential benefit justifies potential risk (category unknown)

Avoid Interactions

Pentoxifylline may interact with other medicines, influencing efficacy or safety.

Avoid

  • Concurrent use with anticoagulants such as warfarin, due to increased bleeding risk
  • Combination with other phosphodiesterase inhibitors (e.g., cilostazol) that may amplify vasodilatory effects

Use with caution

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) that can increase gastrointestinal irritation
  • Antihypertensive agents, as additive blood‑pressure lowering may occur
  • Certain antibiotics (e.g., macrolides) that can affect pentoxifylline metabolism

Frequently Asked Questions

Pentoxifylline is a non‑selective phosphodiesterase inhibitor that increases red blood cell flexibility and reduces blood viscosity, thereby improving microcirculatory blood flow.

Hemovás is commonly prescribed for intermittent claudication due to peripheral arterial disease, chronic venous insufficiency, and other forms of peripheral vascular disease.

No, Hemovás is classified as a prescription‑only medication (Rx) in the EU and must be prescribed by a qualified healthcare professional.

Patients with renal impairment may require dose adjustment, and clinicians should evaluate kidney function before initiating therapy.

The most common side effects include nausea, headache, dizziness, flushing, and diarrhea.

Because pentoxifylline can affect platelet function and bleeding risk, physicians often advise discontinuing it before major surgical procedures.

Concurrent use with anticoagulants may increase bleeding risk, so careful monitoring or alternative therapy should be considered.

Pentoxifylline can have additive blood‑pressure‑lowering effects, so blood pressure should be monitored when used together with antihypertensives.

The pregnancy category for pentoxifylline is unknown; it should only be used if the potential benefit justifies any possible risk to the fetus.

Clinical response varies, but some patients report symptom relief within a few weeks of consistent therapy.

They should seek immediate medical attention, as severe reactions can include rash, swelling, and difficulty breathing.

Pentoxifylline is available as a generic drug in many markets; Hemovás is a brand name for the same active ingredient.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pentoxifylline

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT